Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You missed .80 on July31. No back to the future here.
December to remember?? Topline data anything like we saw mid-trial we could see double digits quite easily.
Anavex A-273 trial in home stretch. September 2015 (Final data collection date for primary outcome measure) Trial update at anytime.
Hasn't it always been the 2016 time frame?? Estimated Primary Completion date:June 2016.
And once again weak hands will be sorry they sold.
July22 PR: Anavex Presents Positive Initial Phase 2a Study Data With ANAVEX 2-73 Showing Early Evidence of Improving Cognition in Patients With Alzheimer’s Disease at AAIC 2015.
"Improved cognition"(the mental action or process of acquiring knowledge and understanding through thought). What other AZ drug can make that claim??
Good to know. Thanks.
Completion of p2 patient enrollment announced today.
Wow thanks for that great post. Yes >90 effective AND a oral rinse is huge even enormous. I'm sure Leo will give updates on patient enrollment from time to time. Just a guess but high efficacy could be read into enrollment speed.
SGX942 study is IV 2x week after radiation treatment requiring clinician to dose. I'm hoping B-OM oral rinse will be a prescription that a patient could dose at home saving money.
Go to Avanex website--leadership--Tangui Nicolas Maurice, Ph.D.
I'm new to Avanex myself.
Yes. Like an intern report from the safety committee.
Fear selling begats fear selling and sh#t runs down hill.. Anyway right now biotech is seeing weakness.
All I can say is wow!! Haven't you noticed the broader market, this damn stock is holding up well.
Hey slcimmuno some Anavex A-273 early data from AAIC poster PR.
Anavex Presents Positive Initial Phase 2a Study Data With ANAVEX 2-73 Showing Early Evidence of Improving Cognition in Patients With Alzheimer’s Disease at AAIC 2015.
http://finance.yahoo.com/news/anavex-presents-positive-initial-phase-110000814.html
A-273 is open label not blinded so further trial updates at anytime. Top line data soon after September completion date. Wouldn't want to be caught on the sidelines with this one.
Huh, any AVXL DD?
Yes. I see another trial as having more eggs in more baskets but I also see a down side right now as we wait for positive trial results to back up the future plans. B-OM has a lot riding on it.
I'm sure the design is still being worked out then we will have a start date. Shouldn't be much longer. July PR said B phase3 is a go.
Your bearish posts don't sway me. I'm a shareholder dug in like a Georgia tick looking to make money on a very good bio play. I leave the resistance issue up to the developers who are on the front lines developing tomorrows bacterial resistant drugs. Go CTIX
Trial evidence has shown Brilacidin works well against gram+ bacteria. Phase 2b trial proved >90 effective against ABSSSI in a single dose making FDA approval seem likely. I take Leo and company word for it and for one am not focusing on the next 10 years pondering will or will it not build a bacterial resistance to it.
I wouldn't sell a share going forward. B-ABSSSI phase3 on deck. K feedback remains stellar. B-OM has a very high chance of seeing therapeutic benefit. If P sees the high therapeutic benefit as expected in it's pill form we are gold. The short selling is based on other influences not at all associated with our ongoing trials.imo
You posted yesterday that you were selling and buying back at .24?
This is the classic example as to why one never sets stops in a OTC. Way to volatile. News will be out soon announcing upcoming bio events. Also earth shattering A-273 topline results expected next month. Good luck.
Brilacidin has already been approved to phase3 for ABSSSI.
B-OM is a topical oral rinse making it likely to have same great outcome cross over to human studies.
A huge amount of excellent pre-clinical studies was used to pave the way for the ongoing clinical trials.
All I can say Bobby is once you have been drug through the mud as severely as CTIX was it's going to take a while to get pretty again. Don't worry, Leo has a lot of good news right around the corner to bring back the shine.
CTIX is beautiful on the inside.
Exactly. Great post.
Exactly. Great post.
Totally Agree. Per the July20 great news PR "FDA agreed to advancing Brilacidin into phase3". Multi-billion dollar single dose ABSSSI drug going into phase3 is huge for ctix.
Thank you for the response. Will follow closely.
Thanks for that compelling DD.
You say possibly some sort of agreement in place. Are there more then one patent?
Question? Why wouldn't a biotech such as Bayer just request to license cell in a box. If Bayer was truly interested wouldn't they first request a sample to test in their own trial and if it worked just do a license agreement. Why buy the company just to use their intellectual property. What am I missing.
Now that's the ticket!
Thinking we should charter a couple buses.
The difference sunspotter is that Cellceutix is NOT a scammy would-be-biopharmaceutical as your posts would elude too.
Leo may now enter into a B-ABSSSI phase3 big pharma partnership. Partnership would put Cellceutix pipeline on the map and boost share price to uplist. The value of Brillacidin as a new class antibiotic has only increased.
Exactly. Further validation reverses chart big time.